Yonaxis I.P. Law Group Logo
Category: patent | Yonaxis I.P. Law Group

Category: "patent"

of 30

Patent Venue Post-TC Heartland Begins to Take Shape

Back in May 2017, the U.S. Supreme Court ruled in T.C. Heartland, LLC v. Kraft Foods Group Brands LLC, that patent venue selection was limited to the defendant’s state of incorporation or principal...

Fed Circuit Watch: Regeneron Denied Redemption in Misconduct Case

On December 26, 2017, the Court of Appeals for the Federal Circuit denied a request for rehearing en banc for reconsideration made by Regeneron Pharmaceuticals, Inc., in a precedential decision....

SCOTUS Watch: Oral Arguments in Oil States

On November 27, 2017, the U.S. Supreme Court heard oral arguments in the Oil States Energy Services, LLC v. Greene’s Energy Group, LLC. This case is discussed in a previous blog posting, but as a...

SCOTUS Watch: Oil States Oral Hearing Preview

On November 27, 2017, the U.S. Supreme Court will hear oral arguments in the appeal from the Court of Appeals for the Federal Circuit, Oil States Energy Services v. Greene’s Energy Group. Certiorari...

USPTO Finalizes New Patent Fee Schedule

|

On November 14, 2017, the USPTO issued its final rule on new fees for Fiscal Year 2017. There are some marked increases, several moderate increases, some nominal increases, a few new fees, and some...

USPTO Issues Public Comments for §101 Subject Matter Eligibility

By Brent T. Yonehara On July 30, 2017, the USPTO released its §101 report, Patent Eligible Subject Matter: Report on Views and Recommendations From the Public. The report is a rather dry recitation...

SCOTUS Watch: Cert Granted in Oil States: the Constitutionality of IPR Proceedings

|

By Brent T. Yonehara On June 12, 2017, the U.S. Supreme Court granted the petition for certiorari in Oil States Energy Services v. Greene’s Energy Group, LLC. Of the three issues presented by...

Fed Circuit Watch: Helsinn and the On-Sale Bar

By Brent T. Yonehara On May 1, 2017, the Federal Circuit Court of Appeals decided Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc., 2016-1284, 2016-1787 (Fed. Cir. 2017), holding that the...

of 30